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Abstract
Primary immunodeficiencies are a group of genetically determined disorders with diverse 
presentations. The purpose of this review is to provide a practical and brief description of a select 
number of these diseases and to discuss the important role the radiologist can have in making an 
early diagnosis and in detecting and following disease complications. The role of diagnostic 
imaging and informed performance and interpretation are vital in the diagnosis, surveillance and 
management of all primary immunodeficiency disorders.
Introduction
Primary immunodeficiency diseases (PIDDs) comprise a spectrum of more than 300 distinct 
disorders characterized by defects in the development of specific components of the immune 
system. They are classified according to which functional compartment of the immune 
system is impaired and broadly include humoral, primary cellular or combined, complement, 
and phagocytic disorders (Table 1). Since there is no screening for most of these conditions, 
the diagnosis of a PIDD is not usually made until the patient develops one or multiple 
infections. The diverse nature and variable presentation of PIDDs also make diagnosis a 
challenge. Early diagnosis therefore requires a high index of suspicion in combination with a 
detailed clinical history, thorough physical examination, and supportive ancillary studies. 
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Often times, imaging findings can either indicate the presence of or confirm the diagnosis of 
a PIDD. The radiologist’s familiarity with PIDDs is therefore paramount. We last published 
a comprehensive review of the clinical features and imaging findings of PIDDs in children 
more than a decade ago [1]. In the last 10 years, remarkable progress has been made in the 
discovery of the genetic basis, diagnosis and treatment of PIDDs (Table 2). Our objective is 
to review the spectrum of PIDD disorders, providing relevant imaging features and 
emphasizing notable advancements in selected immunodeficiency disorders.
Humoral immunodeficiency disorders
Primary humoral immunodeficiencies are characterized by defective antibody production 
and include X-linked agammaglobulinemia (XLA), common variable immunodeficiency 
(CVID), selective immunoglobulin A (IgA) deficiency, hyper-IgM syndromes (HIGM) and 
others [2, 3]. The most common primary antibody deficiency is selective immunoglobulin A 
(IgA) deficiency, characterized by an isolated absence of serum or secretory IgA. A closely 
related condition, CVID, is defined by recurrent sinopulmonary infections, low levels of 
most or all serum immunoglobulin classes, and impaired antibody responses. However, in 
contrast to XLA, where B cells are few or absent, the number of circulating B cells is often 
normal in CVID. XLA patients are also panhypogammaglobulinemic, as are many with 
CVID. Due to molecular defects resulting in failure of immunoglobulin class switch 
recombination, HIGM syndromes have normal or elevated levels of serum IgM and absent 
or very low concentrations of IgG, IgA and IgE [4].
Patients with primary humoral immunodeficiencies generally present with recurrent 
bacterial infections, especially those involving the upper and lower respiratory tracts (Fig. 
1). Other significant clinical manifestations include autoimmune disease (Fig. 2), 
particularly autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura, 
lymphoid hyperplasia, and endocrine abnormalities [5]. CVID and selective IgA deficiency 
patients are also at increased risk of malignancy, particularly lymphoma and gastrointestinal 
cancers.
Imaging findings can aid in the diagnosis of primary humoral immunodeficiencies. 
Radiographically, children with XLA classically have sparse lymphoid tissue so the tonsillar 
and adenoidal tissues are reduced in amount. Antibody-deficient patients demonstrate both 
upper and lower airway abnormalities, including pansinusitis, bronchiectasis, bronchial wall 
thickening and atelectasis [1]. Bronchiectasis is more typical in the middle and lower lobes 
than in the upper lobes (Fig. 3) [6]. In contrast to XLA and CVID, bronchiectasis is not a 
common complication in selective IgA deficiency because functioning IgG antibodies are 
usually available [7]. Magnetic resonance imaging performed for central nervous system 
infection in humoral immunodeficiency may demonstrate diffuse leptomeningeal thickening 
and enhancement when contrast media is administered [1]. Other sequelae include cerebral 
atrophy (Fig. 4) and abscesses (Fig. 5).
With imaging, children and adults with CVID may be distinguished from other humoral 
immunodeficiency patients in that they may have normal amounts of tonsillar and adenoidal 
tissue, and up to 25% develop lymphadenopathy and splenomegaly [8]. Patients with CVID 
Wu et al. Page 2
Pediatr Radiol. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
may also develop lymphoid interstitial pneumonia, characterized on chest CT by the 
presence of ground-glass attenuation, poorly defined centrilobular nodules and thickening of 
the interstitium along the lymphatic vessels (Fig. 6) [9]. Nodular lymphoid hyperplasia of 
the gastrointestinal tract is also frequently observed in this population (Fig. 7) [10].
Recurrent infections are a major cause of significant morbidity and sometimes early 
mortality in primary humoral immunodeficiency. Early recognition and diagnosis is 
imperative, as prompt initiation of appropriate therapy can significantly improve patient 
outcome and survival. Early detection and effective treatment of acute infections are also 
vital. The cornerstone in the management of primary antibody deficiency is immunoglobulin 
replacement therapy. In recent years, there has been increased use of subcutaneous 
immunoglobulin replacement therapy. Studies have shown that subcutaneous 
immunoglobulin is equal to intravenous immunoglobulin therapy in effectiveness [5]. 
Adequate immunoglobulin replacement not only lowers the frequency and severity of 
infections, but also increases life expectancy. Management of primary antibody deficiency 
also requires vigilant monitoring for associated complications, including autoimmunity, 
granulomatous disease, lymphoproliferation and malignancy [11–13].
Primary cellular and combined immunodeficiency disorders
Primary cellular and combined immunodeficiencies comprise a heterogeneous group of 
disorders resulting from defects affecting various stages of T cell development or function 
and include severe combined immunodeficiency (SCID), DiGeorge anomaly, Wiskott-
Aldrich syndrome, cartilage-hair hypoplasia, ataxia-telangiectasia and purine nucleoside 
phosphorylase deficiency [14]. These defects may also be associated with decreased 
numbers of other lymphocyte populations, such as B cells and natural killer (NK) cells. 
Though these syndromes share molecular defects causing T cell dysfunction, they differ 
enough to justify being discussed separately.
Severe combined immunodeficiency
Severe combined immunodeficiency (SCID) is a fatal syndrome characterized by profound 
deficiencies of both T cell number and function and, as a consequence, also B cell function, 
since antibody production is T cell dependent. Depending on the underlying molecular 
defect, patients may also have deficiencies of B cells and/or NK cells. In the past 20 years, 
significant progress has been made in identifying molecular causes of SCID. It is now 
known that SCID can be caused by mutations in at least 13 different genes (Table 2), and 
more are likely to be discovered. These include cytokine receptor genes and antigen receptor 
genes, among others [14–16]. Inheritance may be either X-linked or autosomal recessive or 
from de novo mutations.
Patients with primary cellular immunodeficiencies suffer from recurrent and severe 
infections, and suspicion should be raised by infections with opportunistic organisms such as 
Pneumocystis jiroveci pneumonia, Candida albicans and viral pathogens. Infants with SCID 
may also contract infections from live attenuated vaccines including rotavirus, varicella, and 
bacillus Calmette-Guerin (BCG). A history of chronic diarrhea and skin rash may also be 
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present. These patients also exhibit poor growth and failure to thrive. On physical 
examination, there is an absence of tonsillar and other lymphoid tissues [5].
Because T cells comprise 70% of normal circulating lymphocytes, SCID is almost always 
associated with significant lymphopenia due to the absence of T cells [5, 16]. Diagnosis is 
confirmed by the findings of low or absent T cell numbers and absent T cell function in 
vitro. Other characteristic findings include impaired specific antibody responses and low 
serum immunoglobulin levels, though IgG levels may be normal in early infancy due to the 
presence of maternal IgG. Evaluation of all lymphocyte subsets should be performed by 
flow cytometry. Identification of a genetic cause is important, but it is not required to 
proceed with treatment.
A defining radiologic feature of SCID and other severe T cell deficiencies, such as complete 
DiGeorge anomaly, is the absence of thymus [17]. For example, chest radiography 
demonstrates a narrow upper mediastinal contour and retrosternal lucency caused by the lack 
of normal thymic tissue (Fig. 8) [1, 17]. Other radiographic manifestations include severe 
and/or recurrent pneumonias [18]. Pneumocystis typically produces diffuse interstitial 
infiltrates that eventually progress to alveolar infiltrates. Viral pneumonia may be 
radiographically indistinguishable from Pneumocystis pneumonia. Patients with SCID due 
to adenosine deaminase (ADA) deficiency, a subtype characterized by the most profound 
lymphopenia, demonstrate unique skeletal imaging abnormalities including cupping and 
flaring at the costochondral junctions anteriorly, irregularity at the costovertebral junction, 
and an increased separation of the rib head and vertebral body [19]. A “bone-in-bone” 
appearance of the vertebral bodies (Fig. 9) has also been described, but this can be a normal 
appearance in young infants [19]. Infants eventually diagnosed with SCID will often present 
with chest radiographic abnormalities including linear opacities, bronchiectasis, air trapping, 
nodular and ground glass opacities, and interstitial thickening likely related to past, often 
opportunistic, infections prior to the diagnosis of SCID.
Patients suspected of having SCID should be placed in protective isolation and avoid contact 
with potentially ill individuals. Other requirements in the medical management of patients 
with SCID include immunoglobulin replacement therapy, antibiotic prophylaxis against 
Pneumocystis jiroveci pneumonia and early treatment of infections. They should only 
receive irradiated, leukoreduced and cytomegalovirus-negative blood products given the 
risks of lethal graft-versus-host disease (GVHD) and transmission of infections. Live 
attenuated vaccines should be avoided. Perhaps one of the most important determinants of 
long-term outcome is early diagnosis, referral to an immunologist for rapid confirmation of 
the diagnosis and expedited definitive therapy [20].
Hematopoietic stem cell transplantation (HSCT) offers the potential for a permanent cure 
and is currently the standard of treatment for SCID. Though the treatment of choice is an 
allogeneic HSCT from a human leukocyte antigen (HLA)-identical sibling, chances of 
amatched donor are small. Advances in the past 3 decades have improved outcomes of 
patients with SCID undergoing rigorously T cell-depleted, HLA half-matched parental 
HSCT [15, 16, 21]. Immune reconstitution is achieved and survival rates are high, especially 
if a related donor transplant is performed in the first 3.5 months of life without pre-transplant 
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conditioning [15, 16]. Moreover, the vestigial thymus in infants with SCID is functional, as 
evidenced by increasing thymic size post-transplantation and long-term maintenance of 
thymic output [22]. Because patients with SCID lack cellular immunity, HSCT does not 
require pre-transplant chemotherapeutic conditioning. Post-transplant GVHD prophylaxis is 
also not necessary even in the HLA half-matched parental HSCT, since the T cells are 
removed from the graft prior to administration. If GVHD occurs, reactions are usually mild 
and self-limited [15]. Patients with SCID due to ADA deficiency may also receive enzyme 
replacement therapy with PEGylated bovine ADA, but its use is limited by its failure to 
provide adequate or sustained immune reconstitution. An exciting prospect is gene therapy, 
with promising preliminary results in ADA-SCID [23]. Results from trials for gene therapy 
for X-linked SCID were initially promising, but have been complicated by development of 
leukemic transformation due to insertional mutagenesis [24].
It is intuitive and evident that infants with SCID have a better outcome with earlier 
diagnosis, avoidance of infections and prompt restoration of immune function. The 
Secretary of Health and Human Services’ 2010 recommendation that newborn screening for 
SCID be added to the list of conditions routinely performed. The screening test is for T cell 
lymphopenia and is performed on dried blood spots. Thirty-nine states have now initiated 
newborn screening using this method and almost all have detected SCIDs as well as 
complete DiGeorge anomaly in patients and those with other causes of T cell lymphopenia 
[25, 26].
DiGeorge anomaly
DiGeorge anomaly results from defective development of the third and fourth pharyngeal 
pouches and the classic presentation is a triad of thymic hypoplasia or aplasia, conotruncal 
anomalies, and hypoplasia or absence of the parathyroid glands. Complete DiGeorge 
anomaly due to athymia results in profound T cell defects; however, a majority of patients 
have partial DiGeorge anomaly with some thymic function and varying degrees of T cell 
deficiency [5, 27]. Complete DiGeorge anomaly may be further divided into typical or 
atypical phenotypes. Atypical complete DiGeorge anomaly is characterized by an expansion 
of oligoclonal peripheral T cells that infiltrate organs and is therefore often accompanied by 
rash and lymphadenopathy [28, 29]. Patients with DiGeorge anomaly have a heterogeneous 
presentation and may not present with the classic triad of features, emphasizing the need for 
a high index of suspicion.
Approximately 75% of patients with DiGeorge anomaly have congenital heart disease, most 
commonly tetralogy of Fallot, interrupted aortic arch, ventricular septal defects and truncus 
arteriosus (Fig. 10) [27]. Patients may present with seizures during the neonatal period due 
to hypocalcemia resulting from absence of the parathyroid glands. Other associated 
attributes include facial dysmorphism with hooded and down-slanting eyes, low-set ears, 
short philtrum with fish-mouth appearance, micrognathia, palatal defects, feeding 
difficulties, gastroesophageal reflux, speech delay and mental retardation. Other syndromes 
associated with DiGeorge anomaly include CHARGE (coloboma, heart defects, atresia of 
the choanae, retarded growth and development, genitourinary abnormalities and ear 
anomalies) and diabetic embryopathy [27, 28].
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There is a continuum of immunodeficiency in DiGeorge anomaly, ranging from a profound 
T cell immunodeficiency to entirely normal immune function. Fewer than 1% of DiGeorge 
anomaly patients have complete athymia, so immunodeficiency is less commonly the initial 
manifestation. Those with complete DiGeorge anomaly and profound T cell deficiency may 
present similarly to SCID patients, with chronic diarrhea, skin rash, failure to thrive, an 
absence of tonsillar or lymph tissue on exam, and absence of thymus on imaging (Fig. 11). 
Moreover, they are also susceptible to infections with opportunistic pathogens and are at 
significant risk of contracting infections from live attenuated vaccines. Early diagnosis is 
critical as these patients will not survive without immune reconstitution. Patients with partial 
DiGeorge anomaly have variable decreases in T cell numbers, but T cell function is normal 
or only marginally reduced and no immune therapy is required [5, 27].
The diagnosis of DiGeorge anomaly is based on a combination of clinical characteristics and 
ancillary studies. As with SCID, complete DiGeorge anomaly may also be associated with 
significant lymphopenia due to the absence of T cells. Infants with complete DiGeorge 
anomaly will therefore also benefit from instituting newborn screening and earlier diagnosis. 
In vitro evaluations of T cell function and specific antibody responses should also be 
performed. Though B cell function may be compromised from limited T cell help, B cells 
and NK cells are typically present [5]. In addition, patients suspected of having DiGeorge 
anomaly should undergo assessments for cardiac disease and abnormal parathyroid function.
Many, but not all, patients with DiGeorge anomaly have a heterozygous deletion of 
chromosome 22q11.2 detectable by fluorescent in situ hybridization (FISH). Conversely, not 
all patients with hemizygous deletion of 22q11.2 have DiGeorge anomaly [27]. An 
additional molecular defect associated with DiGeorge anomaly is deletion of chromosome 
10p13-14 [5]. Again, genetic analysis should not interfere with or postpone pursuit of 
definitive treatment.
Treatment of DiGeorge anomaly requires a multidisciplinary approach given the wide range 
of clinical features. Correction of hypocalcemia and repair of cardiac defects may be critical 
shortly after birth. Patients with complete DiGeorge anomaly should be placed in protective 
isolation and require antimicrobial prophylaxis. In these patients, administration of live 
attenuated vaccines should be avoided and blood products should be irradiated, 
leukoreduced, and cytomegalovirus negative. Allogeneic thymus transplantation has proven 
to be a promising, life-saving cure with good survival rates and evidence of functional 
immune reconstitution [29]. There is also early interest in parental parathyroid grafts to 
correct the hypoparathyroidism, but further prospective study is needed to optimize success 
of engraftment and function [30]. Patients may otherwise require lifelong calcium and 
vitamin D supplementation.
Combined immunodeficiency disorders
Combined immunodeficiency disorders (CIDs) are a spectrum of diseases characterized by 
reduced, but not absent, T cell function and include (among others) Wiskott-Aldrich 
syndrome, cartilage-hair hypoplasia, ataxia-telangiectasia and purine nucleoside 
phosphorylase deficiency [16]. Though the number of circulating B cells is typically normal, 
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reduced antibody function is often present. CIDs have heterogeneous clinical presentations, 
but there are often distinctive features that serve as diagnostic clues. Wiskott-Aldrich 
syndrome is characterized by the clinical triad of eczema, thrombocytopenia with small 
platelets and immunodeficiency [5, 31]. Clinical manifestations include bloody diarrhea, 
excessive bleeding from a circumcision site and easy bruising. Sinopulmonary infections 
with common pathogens occur most frequently in Wiskott-Aldrich syndrome, though severe 
infections with opportunistic pathogens, such as Pneumocystis jiroveci and herpes simplex, 
also occur. Patients with AT exhibit progressive cerebellar ataxia and deterioration of motor 
skills, oculocutaneous telangiectasia and immunodeficiency [8, 32]. Opportunistic infections 
are rare, but recurrent infections involving the respiratory tract may lead to chronic lung 
disease. Cartilage-hair hypoplasia is a genetic form of metaphyseal chondrodysplasia 
associated with short stature, redundant skin folds of the neck and extremities, and sparse 
hair [5, 33]. Immunodeficiency is also common, and potentially lethal or fatal infections 
with varicella, vaccinia and poliovirus have been described. Wiskott-Aldrich syndrome, 
cartilage-hair hypoplasia and ataxia-telangiectasia also all share a significantly increased risk 
of malignancy.
CIDs are associated with reduced cellular and humoral immune function [5, 31–33]. 
Decreased numbers or percentages of T cells and depressed proliferative responses to 
mitogens are common. There is also often defective antibody-mediated immunity with high 
variability in the concentrations of immunoglobulins. In addition, Wiskott-Aldrich syndrome 
patients typically have thrombocytopenia, and cartilage-hair hypoplasia patients often 
exhibit lymphopenia, anemia, neutropenia or a combination of cytopenias. If a CID is 
suspected, confirmatory testing by mutation analysis can be performed. Wiskott-Aldrich 
syndrome is caused by mutations in the Wiskott-Aldrich syndrome protein (WASP) gene, 
mapped to Xp11.22-11.23 [8, 27]. AT and cartilage-hair hypoplasia are both autosomal 
recessive conditions. The mutated gene in ataxia-telangiectasia (ATM) is located on 
chromosome 11q22-23 [8, 28]. The abnormal gene in cartilage-hair hypoplasia encodes the 
ribonucleic acid (RNA) component of the mitochondrial RNA processing endoribonuclease 
(RMRP) and is located on chromosome 9p21-23 [5, 33].
Imaging studies can often aid in the establishment of a CID. Noteworthy findings are related 
to infectious complications or sequelae and may include otitis media, sinusitis, mastoiditis 
and pneumonia. Imaging findings in Wiskott-Aldrich syndrome include recurrent 
pneumonia, sinusitis and mastoiditis as well as hemorrhage related to thrombocytopenia 
[17]. ataxia-telangiectasia patients demonstrate diffuse cerebellar atrophy, with predilection 
for the cerebellar vermis (Fig. 12) [34]. Patients with Wiskott-Aldrich syndrome and ataxia-
telangiectasia share the highest incidence of malignancy (Fig. 13). Of particular importance 
to ataxia-telangiectasia patients and some types of SCID patients is that imaging studies 
using ionizing radiation must be minimized as possible due to the increased risk of 
malignancy resulting from altered repair mechanisms following deoxyribonucleic acid 
(DNA) damage from radiation exposure. Imaging findings in cartilage-hair hypoplasia are 
similar to those of other CIDs with added skeletal manifestations of short-limbed dwarfism. 
The skeletal dysplasia is characterized by widening, scalloping, and sclerosis of the 
metaphyses of tubular bones (Fig. 14) [35, 36].
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Patients with milder degrees of immunodeficiency do not require immune reconstitution for 
survival, but patients with more severe defects in immunity may require definitive therapy. 
Unfortunately, there is currently no curative treatment option for ataxia-telangiectasia and 
outcome is poor. The most common causes of death are malignancy and advancing 
neurological disease [5]. For other CIDs, HSCT has had good long-term results because of 
improvements in donor selection and post-transplant care in the past decade. Though an 
HLA-identical sibling donor is ideal, comparable results have recently been achieved using 
closely matched related and unrelated donors [31, 33]. In contrast to patients with absent 
cellular immunity, patients with a CID require reduced intensity pre-transplant conditioning 
to ensure successful donor engraftment. Patients should only receive leukoreduced, 
irradiated, and cytomegalovirus-negative blood products. Live attenuated vaccines should 
not be given. In addition, immunoglobulin replacement therapy and antimicrobial 
prophylaxis may also be indicated. Patients with Wiskott-Aldrich syndrome who do not get 
transplantation may need a splenectomy for persistent thrombocytopenia.
Disorders of phagocytic cells and adhesion molecules
Primary phagocytic immunodeficiencies may be divided into disorders associated with 
defects in phagocyte numbers, adhesion, signaling or function [37]. Leukocyte adhesion 
deficiency (LAD) results from genetic mutations affecting molecules essential for neutrophil 
and lymphocyte adhesion to blood vessel walls, with resultant defective chemotaxis and 
lymphocyte killing. The interferon-gamma (IFN-γ) and interleukin-12 (IL-12) pathway is 
pivotal in innate immunity and defects in this axis result in severely impaired defense against 
intracellular pathogens. Chronic granolumatous disease (CGD) is also characterized by 
defective intracellular killing due to mutations involving components of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase, an enzyme instrumental in the 
generation of reactive oxygen species. Disorders involving defective neutrophil granule 
formation and function are rare and include myeloperoxidase deficiency, the Chédiak-
Higashi syndrome and neutrophil-specific granule deficiency.
Phagocyte disorders may have variable presentations, but all share an increased 
susceptibility to infection with bacteria, primarily those on the skin and gut mucosa, and 
fungi. The infections can be severe and refractory to conventional treatment, often a clue of 
an underlying immunodeficiency. In addition to an increased risk of infections, congenital 
neutropenias are characterized by either a chronic or intermittent decrease in neutrophil 
counts. In contrast, LAD is associated with an increase in circulating neutrophil numbers, 
even in the absence of infection, due to abnormal trafficking and inability to egress from the 
vascular system. LAD type I is the most common and is manifested by delayed umbilical 
cord separation, poor pus formation, poor wound healing, periodontal disease and recurrent 
skin infections. Diagnosis may be established by performing flow cytometry to evaluate for 
expression of CD18, which is deficient in LAD type I. LAD types II and III have been 
described in only few patients, but they also present with leukocytosis and recurrent 
infections [38]. Mutations in the IFN-γ and IL-12 pathway are also rare, and patients are 
uniquely susceptible to primarily disseminated mycobacterial and Salmonella species 
infections [5].
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CGD is characterized by recurrent and refractory infections with catalase-positive bacteria 
and fungi, most commonly Staphylococcus aureus, Serratia marescens, Burkholderia 
cepacia, Nocardia and Aspergillus species. In recent years, a novel bacterium Granulibacter 
bethesdensis has been discovered and characterized as a cause of significant infection in 
CGD [39]. In decreasing order of frequency, types of infection include pneumonia, abscess 
formation, suppurative adenitis and osteomyelitis. Frequent sites of abscess involvement 
include subcutaneous tissue, liver, lymph nodes, lung and perirectal area [40]. There is also 
tissue granuloma formation. Diagnosis is confirmed by an abnormal assay of oxidase 
function in the dihydrorhodamine test. Genetic testing is available to confirm presence of 
mutation in an NADPH oxidase subunit. CGD has either an autosomal recessive or, more 
commonly, an X-linked recessive inheritance pattern.
Imaging findings include recurrent and chronic pneumonia, often resulting in pleural 
reaction/thickening or lung abscess (Fig, 15) [41]. Aspergillus infection manifests in a 
variety of radiographic patterns, such as segmental or lobar infiltrates, nodular opacities and 
cavitation [42]. Suppurative lymphadenitis, subcutaneous and chest wall abscesses, and 
osteomyelitis are all known complications of CGD. Esophagitis and esophageal strictures 
have been described in this population [43, 44]. In the abdomen, CGD patients often develop 
hepatic (Fig. 16) and splenic (Fig. 17) abscesses, renal infections and granuloma formation 
leading to bronchial, esophageal and gastric antral narrowing, duodenal fold thickening, 
enteritis and colitis, enteric fistulas and sinus tracts, bladder wall thickening, and ureteral 
and urethral strictures [40, 45–47].
Patients with Chédiak-Higashi syndrome demonstrate nonspecific hilar and mediastinal 
lymphadenopathy and hepatosplenomegaly. Brain imaging demonstrates cerebral atrophy, 
CT hypodensity, and MR T2-hyperintensity in periventricular white matter and corona 
radiata [48].
Early diagnosis and appropriate antimicrobial therapy are the mainstay in the treatment of 
acute infections in patients with phagocytic immunodeficiencies. Long-term antimicrobial 
prophylaxis is also important. The increase in the antifungal armamentarium during the past 
decade with the introduction of voriconazole and posaconazole has contributed to improved 
survival. Abscesses may require invasive surgical drainage. HSCT is a potential curative 
treatment for both LAD and CGD, and available data show promising long-term outcome 
results [49–51]. Filgastrim, a granulocyte colony-stimulating factor analogue, is used in 
chronic neutropenia syndromes and other phagocyte disorders when neutropenia is present.
Other immunodeficiencies
Hyper IgE syndrome
Hyper-IgE syndrome (HIES), also known as Buckley syndrome, is characterized by 
recurrent infections involving the skin and lower respiratory tract, eczematous rash, bone 
and teeth anomalies, and elevated serum IgE levels [5, 52]. Patients invariably suffer from 
recurrent skin abscesses and pneumonias, most commonly due to Staphylococcus aureus. 
Chronic infections with candida and gram-negative bacteria are also frequent. Recurrent and 
chronic infections of the lung often result in pneumatoceles. Musculoskeletal abnormalities 
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include osteopenia with recurrent fractures. Delayed shedding of the primary teeth is also a 
consistent finding. In addition, patients have coarse facial features with a prominent 
forehead, deep set eyes and broad nasal bridge with fleshy nasal tip.
Though elevated IgE levels are typical, they do not correlate with disease severity. IgD levels 
are also elevated in majority of hyper-IgE patients. In addition, blood and sputum 
eosinophils are frequently increased [5]. No specific immune defect occurs consistently in 
patients with HIES, but poor recall antibody responses are most common. Deficiencies 
involving cellular immunity have also been described [5, 52]. Only in the past 5 years have 
the genetic etiologies of HIES been discovered and correlated with clinical phenotype. 
Mutations in signal transducer and activator of transcription 3 (STAT3) are the cause of the 
autosomal dominant form of HIES (AD-HIES). An autosomal recessive form of HIES (AR-
HIES) has recently been described and is due to mutations involving the dedicator of 
cytokinesis 8 (DOCK8) gene [52]. AR-HIES shares certain clinical features with AD-HIES, 
including eczema, recurrent sinopulmonary infections, elevated IgE levels and eosinophilia. 
In contrast to AD-HIES, musculoskeletal and dental abnormalities and development of 
pneumatoceles are rare in AR-HIES [52]. Perhaps the most striking and distinctive feature of 
AR-HIES is the propensity for recurrent cutaneous viral infections, including widespread 
Molluscum contagiosum, warts caused by human papilloma virus, and recurrent herpes 
simplex virus and varicella zoster. Moreover, neurological complications, such as central 
nervous system bleeding and infarction, have been described [52]. Mutations in the gene 
encoding tyrosine kinase 2 (Tyk2) has also been reported in two individuals with AR-HIES 
[52].
Imaging findings in patients with HIES include persistent pneumatocele formation from 
recurrent staphylococcal pneumonias (Fig. 18). These pneumatoceles may become 
extremely large, superinfected and require surgical excision [53]. Fractures after minimal 
trauma are also associated with this syndrome, related to osteoporosis (Fig. 19) [54].
Regardless of the underlying genetic etiology, treatment of HIES requires early detection 
and treatment of infections. Measures to prevent bacterial colonization include antiseptic 
treatments of the skin and continuous antibiotic prophylaxis. Antifungal prophylaxis may 
also be necessary. Patients require resection of pneumatoceles and even pneumonectomy. 
Patients with AD-HIES often survive into adulthood and lead full lives with adequate 
prevention and treatment of infections, though successful allogeneic HSCT has been 
described in two cases [55]. Allogeneic HSCT has also been reported in two patients with 
DOCK8 deficiency [56, 57]. Hyper-IgE patients are at increased risk of malignancy, 
particularly lymphoma. In addition, patients with AR-HIES have an increased rate of 
squamous cell carcinoma likely associated with chronic HPV infection [52].
Conclusion
Primary immunodeficiencies result from a wide variety of molecular defects that adversely 
affect the development and function of the immune system. The variability of the clinical 
features among patients with a primary immunodeficiency demands a high degree of 
suspicion. Many recent advances in the diagnosis and clinical care of these PIDDs have 
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contributed significantly to improved outcome and survival. Timely diagnosis and early 
institution of appropriate therapy, however, is always critical. A radiologist’s familiarity with 
these PIDDs and associated imaging findings is also essential, as imaging plays an integral 
role in both diagnosis and surveillance.
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Fig. 1. 
A 14-year-old girl with hyper-IgM syndrome. Coronal CT image through the midface 
reveals mucosal thickening of the maxillary sinuses as well as near complete opacification of 
the ethmoid air cells. Marked thickening of the nasopharyngeal mucosa is also evident
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Fig. 2. 
A 32-year-old man with X-linked agammaglobulinemia complicated by Crohn disease with 
enterocutaneous fistula. a Intravenous and oral contrast-enhanced axial CT image through 
the pelvis demonstrates punctate foci of air extending through the anterior abdominal wall 
musculature into the subcutaneous fat (arrow). The fat also has increased attenuation due to 
inflammation. Punctate low attenuation focus in the left rectus muscle (arrowhead) probably 
represents a small abscess. b Higher attenuation within the same region in the anterior 
subcutaneous fat represents oral contrast media. Associated bowel wall thickening is also 
present (arrows)
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Fig. 3. 
Intravenous contrast-enhanced CT examination in a 13-year-old boy with common variable 
immunodeficiency. a Axial image at the level of the lower thorax and (b) coronal 
reformation demonstrate lower lobe bronchiectasis (arrows) with atelectasis seen in the right 
middle lobe (arrowheads). Note also areas of air trapping likely from small airways 
inflammation. c Coronal reconstruction from the abdomen and pelvis CT demonstrate 
multiple prominent lymph nodes (arrows)
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Fig. 4. 
MRI of the brain in a 22-month-old boy with X-linked agammaglobulinemia. a T2-weighted 
axial image at the level of the lateral ventricles demonstrates normal appearance of the 
lateral ventricles and periventricular white matter. b MRI performed two years later at a 
similar level shows diffuse volume loss, advanced for age, which has markedly progressed in 
the interval. Interval increase in the size of the lateral ventricles is likely secondary to 
progressive volume loss. There is now also scattered T2 prolongation throughout the 
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supratentorial white matter (arrows) that is believed to be secondary to encephalitis. The 
patient now has a ventricular shunt in place (arrowhead)
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Fig. 5. 
MRI of the brain in a 2-year-old boy with X-linked agammaglobulinemia. Post-contrast 
axial T1-weighted (a) and 3-D spoiled gradient echo (b) images demonstrate a rim-
enhancing lesion in the right cerebellum (arrows), representing an abscess
Wu et al. Page 24
Pediatr Radiol. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 6. 
Unenhanced CT chest at the level of the heart using lung window and levels in a 28-year-old 
man with common variable immunodeficiency and lymphoid interstitial pneumonia shows 
diffuse bronchiectasis that was predominately distributed in the lower lobes, with nodular 
opacities due to lymphocytic infiltration, and small bilateral pleural effusions (better seen 
with soft-tissue window and level)
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Fig. 7. 
A 13-year-old boy with common variable immunodeficiency and lymphoproliferation in the 
abdomen. Coronal enhanced CT image demonstrates enlarged lymphoid tissue in the porta 
hepatis and retroperitoneal regions (arrows). The spleen is markedly enlarged
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Fig. 8. 
A 7-month-old boy with severe combined immunodeficiency. a Frontal chest radiograph 
demonstrates a narrow mediastinal contour. b Absent thymic tissue is evident as a prominent 
anterior clear space on the lateral view. Hyperinflation is present and there are patchy areas 
of heterogeneous opacification, most likely representing atypical infection, which is often 
both chronic and acute with small airways disease and air trapping
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Fig. 9. 
A 2-month-old boy with severe combined immunodeficiency due to adenosine deaminase 
deficiency. a Frontal chest radiograph demonstrates narrow superior mediastinum, and (b) 
lateral view shows prominent anterior clear space due to thymic absence. Anterior rib 
cupping at the costochondral junctions is particularly evident on the right side (arrows in a)
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Fig. 10. 
IV contrast-enhanced chest CT in a 2-year-old boy with complete DiGeorge anomaly status 
post repair of pulmonary atresia and unrepaired ventricular septal defect. a Axial image at 
the level of the aortic arch demonstrates a right-side arch with an aberrant left subclavian 
artery (arrow) and no thymic tissue. b Axial image at the midventricular level shows the 
large ventricular septal defect (*), a small right ventricle (RV) and the right-side descending 
thoracic aorta (arrow)
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Fig. 11. 
A 2-month-old boy with DiGeorge anomaly. Sagittal volumetric interpolated breath-hold 
examination (VIBE) post-contrast image shows cardiac tissue directly apposed to the chest 
wall without intervening thymus
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Fig. 12. 
A 6-year-old girl with ataxia telangiectasia. Three-dimensional axial T1 acquisition in 
coronal (a) and sagittal (b) planes. The cerebellum is atrophic, with thinning of the 
cerebellar cortex both laterally as well as in the vermis
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Fig. 13. 
Same patient as in Fig. 12 with ataxia telangiectasia, now 8 years old and with mucosa-
associated lymphoid tissue (MALT) lymphoma. a Coronal maximum intensity projection 
image from 18-Fluorodeoxyglucose positron emission tomography (FDG-PET)/CT 
examination demonstrates abnormal radiotracer uptake in the stomach. b Axial CT image 
from FDG-PET/CT examination demonstrates wall thickening of the stomach (arrow) 
correlating with FDG avidity
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Fig. 14. 
A 10-month-old boy with cartilage-hair hypoplasia. Frontal radiographs of the lower 
extremities demonstrate bowing and metaphyseal flaring and growth plate irregularity
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Fig. 15. 
A 14-year-old boy with chronic granolumatous disease. Axial image (a) and coronal 
reformation (b) from noncontrast enhanced CT of the chest (lung window and level images) 
demonstrate right lower and middle lobe consolidation and cavitation [arrows in (a) and (b)] 
due to pneumonia. Right pleural effusion was better seen on soft-tissue window and level. 
There is also scarring and some cavitary change seen in the left upper lobe in (b) due to prior 
infection
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Fig. 16. 
A 19-month-old boy with chronic granolumatous disease and liver abscesses. a Coronal 
half-Fourier acquired single-shot turbo spin echo (HASTE) from an MRI of the abdomen 
and pelvis demonstrates targetoid T2 hyperintense foci representing abscesses in the right 
and left lobes of the liver. b Corresponding focused transverse US image of the left lobe of 
the liver demonstrates an ill-defined, septated hypoechoic abscess
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Fig. 17. 
A 32-year-old boy with chronic granolumatous disease and splenic abscesses. Axial 
intravenous contrast-enhanced images at the level of the splenic hilum superiorly (a) and 
more inferiorly (b), show innumerable tiny low attenuation splenic lesions representing 
microabscesses. There is also marked splenomegaly
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Fig. 18. 
A 17-year-old girl with hyper-IgE syndrome. Axial CT image demonstrates thin-walled 
cystic lucencies in the bilateral lower lobes representing pneumatoceles
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Fig. 19. 
Sagittal reformatted CT image of the lower thoracic and lumbar spine in a 27-year-old man 
with hyper-IgE syndrome. Compression deformity of the T12 vertebral body is likely due to 
syndrome-related osteoporosis
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Table 1
Clinical findings in the major subgroups of primary immunodeficiency disorders
Subgroup Patterns of infections Other notable features
Humoral immunodeficiency disorders
X-linked agammaglobulinemia
Common variable immunodeficiency
Selective IgA deficiency
Hyper-IgM syndromes
Recurrent bacterial sinopulmonary infections with 
encapsulated organisms
(Haemophilus influenzae, pneumococci, 
streptococci)
Chronic or recurrent gastroenteritis
(enterovirus, Giardia lamblia)
Chronic enteroviral meningoencephalitis
Septic arthritis
(mycoplasma, ureaplasma)
Autoimmunity, including AIHA, ITP, 
IBD
Nodular lymphoid hyperplasia
Bronchiectasis
Primary cellular and
combined immunodeficiency disorders
Severe combined immunodeficiency
DiGeorge anomaly
Wiskott-Aldrich syndrome
Cartilage-hair hypoplasia
Ataxia-telangiectasia
PNP deficiency
Severe or unusual viral infections
Fungal infections, including oral thrush
(Candida albicans)
Pneumocystis jiroveci pneumonia
Post-vaccination disseminated BCG infection
Failure to thrive
Chronic diarrhea and malabsorption
Graft-versus-host disease
Congenital heart disease (DiGeorge 
anomaly)
Cytopenias
Phagocytic disorders
Leukocyte adhesion deficiency
Chronic granulomatous disease
IFN-γ/IL-12 pathway
Myeloperoxidase deficiency
Chédiak-Higashi syndrome
Neutrophil-specific granule deficiency
Skin abscesses and lymphadenitis
Bacterial pneumonia
Recurrent infections with catalase positive organisms 
and fungi (CGD)
(Staphylococcus aureus, Serratia marescens, 
Burkholderia cepacia
Nocardia and Aspergillus)
Chronic periodontal disease
Delayed separation of the umbilical cord 
(LAD)
Complement disorders
Recurrent Neisserial infections
Pyogenic bacterial infections with encapsulated 
organisms
Autoimmunity, including RA and SLE
Hereditary angioedema
Other immunodeficiencies
Hyper IgE syndrome
Recurrent bacterial pneumonias
(Staphylococcus aureus, Haemophilus influenzae, 
pneumococci)
Staphylococcal skin abscesses
Pneumatoceles (may be suprainfected with 
Pseudomonas and Aspergillus)
Chronic mucocutaneous candidiasis
Cutaneous viral infections
(Molluscum contagiosum, HPV, HSV, VZV)
Severe eczema
Osteopenia and pathological fractures
Delayed shedding of primary teeth
Elevated serum IgE levels and 
eosinophilia
CNS bleeding and infarction
AIHA autoimmune hemolytic anemia, BCG bacillus Calmette-Guérin, CGD chronic granulomatous disease, CNS central nervous system, HPV 
human papillomavirus HSV herpes simplex virus, IBD inflammatory bowel disease, IFN interferon, Ig immunoglobulin, IL interleukin, ITP 
idiopathic thrombocytopenic purpura, LAD leukocyte adhesion deficiency, PNP purine nucleoside phosphorylase, RA rheumatoid arthritis, SLE 
systemic lupus erythematosus. VZV varicella zoster virus
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Table 2
Genetic defects leading to primary immunodeficiency diseases
Chromosome Primary immunodeficiency disease
Humoral immunodeficiency disorders
X-linked agammaglobulinemia (XLA) and agammaglobulinemia
10q23.2-q23.33 Agammaglobulinemia due to BLNK deficiency
19p13.2 Agammaglobulinemia caused by mutations in Iga gene
22q11.2 Agammaglobulinemia caused by mutations in λ5 surrogate light-
chain gene
Xq22 XLA caused by Bruton tyrosine kinase (Btk) deficiency
Common variable immunodeficiency (CVID)
2q33 Autosomal recessive CVID due to ICOS deficiency
6p21.3 (?) CVID and selective IgA deficiency
16p11.2 CVID due to CD19 deficiency
17p11.2 CVID or selective IgA deficiency due to TACI deficiency
22q13.1-q13.3 CVID due to BAFF-R deficiency
Hyper-IgM syndrome
12 Hyper-IgM caused by deficiency of uracil-DNA glycosylase
12p13 Hyper-IgM caused by deficiency of activation-induced cytidine
deaminase
20q12-q13.2 Hyper-IgM due to CD40 deficiency
Xq26 Hyper-IgM caused by CD154 (CD40 ligand) deficiency
Primary cellular and combined immunodeficiency disorders
Severe combined immunodeficiency (SCID)
1q22-q25 SCID due to CD3 δ-chain deficiency
1q31-q32 SCID due to CD45 deficiency
5p13 SCID or Omenn syndrome due to IL-7 receptor α-chain deficiency
10p13 SCID (Athabascan, radiation sensitive) due to mutations in the
Artemis gene
11p13 SCID or Omenn syndrome caused by RAG-1 or RAG-2 deficiencies
11q23 SCID or non-SCID due to CD3 γ- δ-, or ε- chain deficiencies
19p13.1 SCID due to Janus kinase 3 (Jak3) deficiency
20q13.2-q13.11 SCID due to adenosine deaminase (ADA) deficiency
Xq13.1-q13.3 X-linked SCID due to common γ-chain (γc) deficiency
2q35 CID with microcephaly due to Cernunnos deficiency
DiGeorge anomaly
10p13 DiGeorge anomaly/velocardiofacial syndrome
22q11.2 DiGeorge anomaly/velocardiofacial syndrome
Combined immunodeficiency disorders
Xp11.22 Wiskott-Aldrich syndrome (WAS) caused by WAS protein (WASP)
deficiency
9p13 Cartilage-hair hypoplasia due to deficiency of RNA component of
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Chromosome Primary immunodeficiency disease
mitochondrial RNA-processing endoribonuclease
11q22.3 Ataxia-telangiectasia (AT), attributable to AT mutation, causing
deficiency of DNA-dependent kinase
14q13.1 Purine nucleoside phosphorylase (PNP) deficiency
Disorders of phagocytic cells and adhesion molecules
Leukocyte adhesion deficiency (LAD)
21q22.3 LAD type 1 (LAD-1) caused by CD18 deficiency
11q14.3-q21 LAD-2 due to deficiency of sialyl LewisX
Interferon-gamma (IFN-γ) and interleukin-12 (IL-12) pathway defects
5q31.1-q33.1 IL-12 p40 deficiency
19p13.1 IL-12R β-chain deficiency
6q23-q24 IFN-γ receptor 1 deficiency due to α-chain deficiency
21q22.1-q22.2 IFN-γ receptor 2 deficiency due to β-chain deficiency
Chronic granulomatous disease (CGD)
1q25 CGD caused by gp67phox deficiency
7q11.23 CGD caused by gp47phox deficiency
16q24 CGD caused by gp22phox deficiency
Xp21.1 CGD caused by gp91phox deficiency
BLNK B-cell linker, CID combined immunodeficiency disorder, DNA deoxyribonucleic acid, gp gene product, ICOS inducible T-cell co-
stimulator, IFN interferon, Ig immunoglobulin, IL interleukin, phox phagocytic oxidase, RAG recombination-activating gene, RNA ribonucleic 
acid, TACI transmembrane activator and CAML (calcium-modulator and cyclophilin ligand) interactor
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